Search Within

Even Holth Rustad

Formats
  1. Meeting Abstract (18)
  2. Journal Article (16)
  3. Review (5)
  4. Research Letter (3)
Groups
  1. Sloan Kettering Institute Postdocs (42)
  2. Department of Medicine (41)
  3. Hematologic Malignancies, Division of (41)
  4. Center for Hematologic Malignancies (37)
  5. Myeloma (37)
  6. Hematologic Malignancies Research (35)

More Groups

People
  1. Carl Landgren (34)
  2. Malin Hultcrantz (29)
  3. Venkata Yellapantula (27)
  4. Francesco Maura (24)
  5. Elli Papaemmanuil (17)
  6. Sham Mailankody (16)

More People

Years
  1. 2021 (8)
  2. 2020 (16)
  3. 2019 (13)
  4. 2018 (5)
Publications
  1. Blood (15)
  2. Best Practice and Research: Clinical Haematology (3)
  3. Blood Cancer Journal (3)
  4. JAMA Oncology (3)
  5. Nature Communications (3)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (8)
  3. Elsevier Inc. (4)
  4. American Medical Association (3)
  5. Elsevier Science, Inc. (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
    Journal Article

    Maclachlan, K. H.; Rustad, E. H.; Derkach, A.; Zheng-Lin, B.; Yellapantula, V.; Diamond, B.; Hultcrantz, M.; Ziccheddu, B.; Boyle, E. M.; Blaney, P.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Positive selection as the unifying force for clonal evolution in multiple myeloma
    Research Letter

    Diamond, B.; Yellapantula, V.; Rustad, E. H.; Maclachlan, K. H.; Mayerhoefer, M.; Kaiser, M.; Morgan, G.; Landgren, O.; Maura, F.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Journal Article

    Maura, F.; Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V. D.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • mmsig: A fitting approach to accurately identify somatic mutational signatures in hematological malignancies
    Journal Article

    Rustad, E. H.; Nadeu, F.; Angelopoulos, N.; Ziccheddu, B.; Bolli, N.; Puente, X. S.; Campo, E.; Landgren, O.; Maura, F.
    Communications Biology (2021)

    Fulltext@MSK | Save
  • Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity
    Review

    Diamond, B. T.; Rustad, E.; Maclachlan, K.; Thoren, K.; Ho, C.; Roshal, M.; Ulaner, G. A.; Landgren, C. O.
    Blood Reviews (2021)

    Fulltext@MSK | Save
  • Routine evaluation of minimal residual disease in myeloma using next-generation sequencing clonality testing: Feasibility, challenges, and direct comparison with high-sensitivity flow cytometry
    Journal Article

    Ho, C.; Syed, M.; Roshal, M.; Petrova-Drus, K.; Moung, C.; Yao, J.; Quesada, A. E.; Benhamida, J.; Vanderbilt, C.; Liu, Y.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • The genomic complexity of multiple myeloma precursor disease can be predicted using copy number signatures on targeted sequencing and SNP array data
    Meeting Abstract

    Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; Landgren, O.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Copy number signatures predict chromothripsis and poor clinical outcome in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; more...
    Blood (2020)

    Fulltext@MSK | Save